Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium Sulfate for Foscarnet-Induced Electrolyte Changes
NCT00002146Phase 4Completed
- Sponsor
- Astra Merck
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of magnesium sulfate in hypocalcemia and hypomagnesemia, sponsored by Astra Merck. Primary endpoints: Incidence of acute ionized hypomagnesemia and Incidence of acute ionized hypocalcemia. Status: completed.
02
Drugs
magnesium sulfate
03
Conditions
hypocalcemiahypomagnesemia
Beyond the preview
Go deeper on NCT00002146.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00002146.